Onderneming Neovasc Inc Toronto S.E.
Aandelen
CA64065J2056
Geavanceerde medische apparatuur & technologie
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sarah Gallagher
CTO | Chief Tech/Sci/R&D Officer | - | 13-07-21 |
Shmuel Banai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alexei J. Marko
BRD | Director/Board Member | 56 | 12-06-03 |
Investor Relations Contact | 54 | 02-04-07 | |
Lisa Becker
LAW | General Counsel | - | 13-07-21 |
John Panton
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Rubin
CHM | Chairman | 63 | 01-02-08 |
Paul Geyer
BRD | Director/Board Member | 61 | 02-11-00 |
Alexei J. Marko
BRD | Director/Board Member | 56 | 12-06-03 |
Douglas Janzen
BRD | Director/Board Member | 56 | 02-06-05 |
Norman J. Radow
BRD | Director/Board Member | - | 16-09-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 783 553 | 2 556 708 ( 91,85 %) | 0 | 91,85 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,82% | 218 mld. | |
+10,04% | 189 mld. | |
+27,77% | 151 mld. | |
+32,12% | 113 mld. | |
-0,15% | 64,02 mld. | |
+14,09% | 52,6 mld. | |
+1,85% | 49,85 mld. | |
-5,80% | 37,89 mld. | |
+0,47% | 34,92 mld. |